3o23: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3o23.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_3o23", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_3o23| PDB=3o23 | SCENE= }} | |||
===Human unphosphorylated IGF1-R Kinase domain in complex with an hydantoin inhibitor=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_21441024}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 21441024 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_21441024}} | |||
==About this Structure== | |||
[[3o23]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3O23 OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:021441024</ref><references group="xtra"/> | |||
[[Category: Homo sapiens]] | |||
[[Category: Receptor protein-tyrosine kinase]] | |||
[[Category: Dupuy, A.]] | |||
[[Category: Guilloteau, J P.]] | |||
[[Category: Maignan, S.]] | |||
Revision as of 06:52, 4 May 2011
Human unphosphorylated IGF1-R Kinase domain in complex with an hydantoin inhibitor
Template:ABSTRACT PUBMED 21441024
About this Structure
3o23 is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Lesuisse D, Mauger J, Nemecek C, Maignan S, Boiziau J, Harlow G, Hittinger A, Ruf S, Strobel H, Nair A, Ritter K, Malleron JL, Dagallier A, El-Ahmad Y, Guilloteau JP, Guizani H, Bouchard H, Venot C. Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: Advantages in comparison with competitive inhibitors. Bioorg Med Chem Lett. 2011 Apr 15;21(8):2224-8. Epub 2011 Mar 4. PMID:21441024 doi:10.1016/j.bmcl.2011.03.003
